Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
BPGbio Inks 70K-SF HQ in Waltham
Lincoln Property Company, Cresa Boston, and BPGbio, Inc. announced BPGbio’s lease of 70,000 square feet at 300 Third Avenue in Waltham, MA. The AI-powered biopharma plans to relocate its headquarters from Framingham and expand into two full floors by June 2025.
The new facility will house their biobank and support drug development and partnerships. 300 Third Avenue, a purpose-built life science building, offers LEED Gold certification and amenities like a roof deck and fitness center. “Our new facility will also house our 100,000+ sample rich biobank, which forms the basis of our unique biology-first, AI-powered drug development, and fuel successful partnerships with pharma, academic, and government partners.” said Niven R. Narain, Ph.D., CEO of BPGbio.
Lincoln’s Tim Latham, Christopher Scott, and Chris Devaux represented ownership, while Cresa Boston’s Paul Delaney, Adam Subber, and Nate Heilbron represented BPGbio. The company joins Biocytogen at the site.